Skip to content

Clinical trials

Acute Coronary Syndrome trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Country / region: New Zealand Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20094
20103
20111
20141
20151
20161
20181
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Aarhus University Hospital Skejby1
Amarin Pharma Inc.1
Anthera Pharmaceuticals1
Baim Institute for Clinical Research1
Biotronik, Inc.1
Bristol-Myers Squibb1
CSL Behring1
DalCor Pharmaceuticals1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome18
Cardiovascular Diseases5
Myocardial Infarction5
Myocardial Ischemia5
Coronary Artery Disease4
Heart Diseases3
Stroke3
Angina Pectoris2
Atherosclerosis2
Coronary Disease2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.